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ABSTRACT 
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Patient studies have suggested that the clinical phenotypes of some 
mitochondrial diseases might transit from one disease to another (e.g., Pearson 
syndrome [PS] to Kearns-Sayre syndrome [KSS]) in single individuals carrying 
mitochondrial (mt) DNA with a large-scale deletion (∆mtDNA), but there is no direct 
experimental evidence for this. To determine if ∆mtDNA has the pathological potential 
to induce multiple mitochondrial disease phenotypes, I used trans-mitochondrial mice 
with a heteroplasmic state of wild-type mtDNA and ∆mtDNA (mito-mice∆). Late-stage 
embryos carrying ≥50% ∆mtDNA showed abnormal hematopoiesis and iron metabolism 
in livers that were partly similar to PS (PS-like phenotypes), although they did not 
express sideroblastic anemia that is a typical symptom of PS. More than half of the 
neonates with PS-like phenotypes died by 1 month after birth, while the rest showed a 
decrease of ∆mtDNA load in the affected tissues, peripheral blood and liver, and they 
recovered from PS-like phenotypes. The proportion of ∆mtDNA in various tissues of the 
surviving mito-mice∆ increased with time, and KSS-like phenotypes were expressed 
when the proportion of ∆mtDNA in various tissues reached >70%-80%. My model 
mouse study clearly showed that a single ∆mtDNA was responsible for at least two 
distinct disease phenotypes at different ages and suggested that the level and dynamics 
of ∆mtDNA load in affected tissues would be important for the onset and transition of 
mitochondrial disease phenotypes in mice.  
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ABBREVIATIONS 
 
B6  C57BL/6 
  COX  cytochrome c oxidase 
  ∆mtDNA  mitochondrial DNA with a large-scale deletion 
E  embryonic day 
KSS  Kearns–Sayre syndrome 
mito-mice∆ mice with ∆mtDNA 
mtDNA  mitochondrial DNA 
PEO  progressive external ophthalmoplegia 
PS  Pearson syndrome 
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Pathogenic mtDNAs having a large-scale deletion (∆mtDNA) or a point mutation, 
induce defects of mitochondrial oxidative phosphorylation (mitochondrial respiration defects) 
and manifest a wide variety of mitochondrial diseases (Larsson and Clayton. 1995; Wallace. 
1999). It has been well documented that ∆mtDNA is responsible for three clinical phenotypes 
of mitochondrial diseases: Kearns–Sayre syndrome (KSS), progressive external 
ophthalmoplegia (PEO), and Pearson syndrome (PS) (DiMauro and Garone. 2011). KSS is 
usually sporadic and is characterized by early onset (<20 years of age), lactic acidosis, 
chronic progressive external ophthalmoplegia, pigmentary retinopathy, heart block, diabetes, 
deafness, cerebellar abnormalities, and renal failure. PEO is mainly a skeletal muscle disorder 
and is characterized by late-onset progressive external ophthalmoplegia, lactic acidosis, 
myopathy, and exercise intolerance. PS is a rare disorder of early infancy that is characterized 
mainly by sideroblastic anemia. At present, the precise mechanism by which ∆mtDNA can 
cause different disease phenotypes is unclear, although it has been considered that different 
loads of ∆mtDNA in tissues are important to establish the multiple disease phenotypes. 
Some patient studies have reported the possibility that infants with PS who survive 
into childhood develop the clinical features of KSS (Larsson et al. 1990; McShane et al. 
1991; Rotig et al. 1995). Furthermore, Larsson and colleagues suggested that the transition of 
disease phenotypes is governed by the fractional concentration of ∆mtDNA in various tissues 
(Larsson et al. 1990); however, there is currently no experimental evidence for this. Since 
mitochondrial function is regulated both by nuclear DNA and mtDNA (Larsson and Clayton. 
1995), it is possible that nuclear genomic background is involved in the pathogenesis of 
different disease phenotypes. Supporting evidence of this is the finding that the homoplasmic 
state of a pathogenic mutant mtDNA does not always induce serious clinical phenotypes in a 
mother and her children (McFarland et al. 2002).  
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Here, to experimentally resolve the question of whether mitochondrial disease 
phenotypes can change in single individuals due to the dynamics of the proportion of 
∆mtDNA in various tissues, I have used a mouse model carrying pathogenic ∆mtDNA. 
Previously, my colleagues succeeded in generating a trans-mitochondrial mouse model 
(mito-mice∆) with a heteroplasmic state for wild-type mtDNA and ∆mtDNA with a 4,696-bp 
deletion from nucleotide position 7,759 of the tRNALys gene to position 12,454 of the ND5 
gene (see Figure 1) (Inoue et al. 2000). The ∆mtDNA introduced in mito-mice∆ is similar to 
the pathogenic mutant mtDNA with the “common deletion” that is found in patients with KSS 
or PS (Holt et al. 1988; Larsson et al. 1990; McShane et al. 1991; Rotig et al. 1995). Since 
the mito-mice∆ all share the same nuclear genomic background (C57BL/6, also called B6), 
their genetic variation is restricted to the load of ∆mtDNA in various tissues. The mito-mice∆, 
therefore, would provide the direct experimental evidence whether a single ∆mtDNA could 
cause the onset and transition of different mitochondrial disease phenotypes. 
By using these mito-mice∆, I investigated whether ∆mtDNA possesses a pathogenic 
potential for the onset of two distinct phenotypes of mitochondrial diseases, PS-like and 
KSS-like phenotypes, early in life (days 1−34 after birth) and in midlife (6 months of age), 
respectively. I also observed that the mice that escaped from the early death probably due to 
PS-like phenotypes developed KSS-like phenotypes in middle age, showing the transition of 
distinct mitochondrial disease phenotypes in single mito-mice∆. 
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Mice 
 Thirty-three female mito-mice∆ carrying 1%–63% ∆mtDNA at 2–6 months of age 
were used as mothers. Embryos on E18.5 and progeny were used for the study. Age-matched 
wild-type B6 mice were used as normal controls. All animal experiments were performed in 
compliance with the institutional guidelines of the University of Tsukuba for the care and use 
of laboratory animals. 
 
Estimation of ∆mtDNA proportion in tissues 
 Proportions of wild-type mtDNA and ∆mtDNA were determined by using real-time 
PCR, as described previously (Sato et al. 2005). Tail samples were used to deduce the 
∆mtDNA load in mito-mice∆. The proportion of ∆mtDNA was also examined in various 
tissue samples (peripheral blood, liver, kidney, and eye). 
 
Cytological and histological analysis 
 Blood samples were smeared on glass slides, and inclusions in reticulocytes were 
visualized by staining with new methylene blue. Cells with granular network inclusions that 
are a typical structure of reticulocytes were counted (see open arrowheads in Figure 6A) and 
proportion of these reticulocytes to 1,000 red blood cells was estimated. The proportion of 
reticulocytes in blood samples of mito-mice∆ and age-matched controls was measured. To 
detect the accumulation of ferric iron, paraffin-embedded sections (5-μm thick) of liver 
samples were stained with Prussian blue and then Safranin O was used as a counter-staining. 
Eye samples were fixed in Bouin’s solution, and paraffin-embedded sections (8-μm thick) of 
the samples were stained with hematoxylin and eosin. 
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Electron microscopic observation of COX activity 
 An electron microscopic analysis of COX activity was carried out as described 
previously (Nakada et al. 2001; Seligman et al. 1968) with slight modifications. Briefly, 
25-μm cryosections of liver samples were fixed in 2% w/v glutaraldehyde in PBS for 5 min at 
0°C. Ultrathin sections, which were not stained with uranyl acetate or lead nitrate solutions, 
were viewed directly on a transmission electron microscope (model H-7650, Hitachi 
High-Technologies Corporation, Tokyo, Japan). In this analysis, enzymatic activity of COX 
was visualized as a black color (high electron density).  
 
Statistics 
 The Student’s t-test was used to compare groups of data. All values are presented as 
means ± SD. The log-rank test was used to compare survival curves. P values less than 0.05 
were considered to indicate statistical significance. 
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Frequency of early death in mito-mice∆. 
 I first examined the early life spans (1–34 days after birth) of mito-mice∆ carrying 
1%–70% ∆mtDNA in their tails (n = 126). The proportion of ∆mtDNA in individual 
mito-mice∆ was deduced from that in their tails just after birth (day 0). In this assay, I also 
used wild-type B6 mice as a normal control (n = 30). Approximately 20% of wild-type B6 
neonates died on day 1 after birth (Figure 2A), but none died from days 2 to 34 (Figure 2B). 
The early life spans of mito-mice∆ carrying <50% ∆mtDNA in their tails were similar to 
those of wild-type B6 mice (Figure 2, B and C). In contrast, when the ∆mtDNA load in the 
neonates’ tails was ≥50%, the frequency of death on day 1 after birth was definitely increased 
compared with that of wild-type B6 mice (Figure 2A). The mito-mice∆ carrying 50%–70% 
∆mtDNA in their tails continued to die after day 1, and only 34% of these neonates survived 
until day 34 after birth (Figure 2D). 
Although the above results indicated that most mito-mice∆ carrying ≥50% 
∆mtDNA died early (≤34 days after birth), a substantial proportion of the progeny of mothers 
carrying >33% ∆mtDNA died very early (day 1 after birth) (Figure 3). Thus, it was unclear 
that early death was associated with the proportion of ∆mtDNA either in neonates or mothers. 
If the latter were the case, then the frequency of early death of pups would be expected to 
increase with the age of the mother, because ∆mtDNA accumulates in various somatic tissues 
but disappears in eggs with time (Sato et al. 2007). Therefore, I next examined the frequency 
of early death in the first and second litters of three female mito-mice∆ carrying 28% (Mouse 
28), 52% (Mouse 52), and 61% (Mouse 61) ∆mtDNA, respectively, in their tails just after 
birth. As expected, the proportion of ∆mtDNA was much higher in the first litter than the 
second litter (Figure 4A). The rate of early death of pups was greatly and significantly higher 
in the first litter than in the second delivery (Figure 4, A and B, P < 0.05). The proportion of 
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surviving pups from the second litter (Figure 4B) was comparable to that of pups with 
wild-type B6 mothers (Figure 2A), despite the ∆mtDNA load of the mothers’ tails increasing 
with time. Average loads of ∆mtDNA in tail samples were 32.4 ± 21.9% (mean ± SD) and 
57.4 ± 16.8% in live and dead mito-mice∆ pups, respectively. Based on these results, I 
concluded that early death of mito-mice∆ was caused by ∆mtDNA load in neonates but not in 
mothers. 
 
Phenotypic observations of late stage embryos of mito-mice∆. 
 To clarify the reason for the frequent early death in progeny carrying ≥50% 
∆mtDNA in their tails, I examined clinical phenotypes in embryos at embryonic day 18.5 
(E18.5), which is just 1 day before birth. I obtained 55 E18.5 embryos carrying 35%–70% 
∆mtDNA in their tails. I also examined 55 E18.5 embryos from wild-type B6 mice as a 
normal control. None of the E18.5 embryos of wild-type B6 mice showed lethal phenotypes. 
Among the E18.5 embryos from mito-mice∆, three (5.5%) showed lethal phenotypes, and 
their tails carried 66%, 67%, and 70% ∆mtDNA, respectively, indicating that embryonic 
lethal phenotypes were restricted to embryos carrying a high load of ∆mtDNA. A typical 
example of an embryo with a lethal phenotype is shown in Figure 5A (right side): the embryo 
was atrophied and discolored when compared with littermate embryos carrying <66% 
∆mtDNA in their tails. However, there was no significant difference in littermate number 
between normal mice and mito-mice∆ at E18.5 (Figure 5B). Thus, I concluded that the 
embryonic lethality was a rare event that was difficult to relate to the observation of frequent 
early death in mito-mice∆. 
I then examined the relationship between body weight and ∆mtDNA load in tails 
(Figure 5, A and C). The average body weight of wild-type E18.5 embryos was 1.19 ± 0.03 g 
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(n = 7), and that of E18.5 embryos carrying 34%–47% ∆mtDNA (1.20 ± 0.07 g, n = 8) was in 
the normal range. In contrast, a substantially lower body weight was seen in E18.5 embryos 
carrying 52%–66% ∆mtDNA (1.05 ± 0.13 g, n = 14, P < 0.05). Thus, growth retardation was 
induced preferentially in E18.5 embryos carrying ≥50% ∆mtDNA loads in tails, which was 
associated with frequent early death after birth. It is well known that ∆mtDNA is a genetic 
candidate for involvement in the pathogenesis of PS, which is a rapidly fatal disorder of 
infancy characterized mainly by sideroblastic anemia (DiMauro and Garone. 2011). My 
results suggested the possibility that neonates carrying ≥50% ∆mtDNA may show clinical 
phenotypes of PS. I therefore examined whether E18.5 embryos carrying ≥50% ∆mtDNA 
showed sideroblastic anemia. Typical sideroblasts were not observed in peripheral blood 
samples from E18.5 embryos carrying ≥50% ∆mtDNA. In contrast, compared with normal 
E18.5 embryos, the number of reticulocytes in peripheral blood samples from E18.5 embryos 
carrying ≥52% ∆mtDNA showed a statistically significant increase (Figure 6, A and B, P < 
0.05), although the increase was slight. The proportion of reticulocytes in peripheral blood 
samples from E18.5 embryos carrying ≤42% ∆mtDNA was similar to that in samples from 
normal E18.5 embryos (Figure 6, A and B). These data suggested abnormalities of 
hematopoiesis and the resultant onset of mild anemia in E18.5 embryos carrying ≥50% 
∆mtDNA. Because abnormal iron metabolism in liver is observed in cases of sideroblastic 
anemia and PS (Camaschella. 2008; Gurgey et al. 1996), I examined pathological changes in 
liver samples from E18.5 embryos carrying ∆mtDNA. Deposits of ferric iron indicating 
abnormal iron metabolism were preferentially observed in liver samples from E18.5 embryos 
carrying ≥50% ∆mtDNA (Figure 7). Based on these observations, I concluded that ≥50% 
∆mtDNA loads could cause PS-like phenotypes in late-stage mouse embryos, although it was 
not a typical PS. 
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In previous studies of my colleagues using mito-mice∆, accumulation of 
approximately 70%–80% ∆mtDNA loads in various tissues was necessary to induce 
mitochondrial respiration defects, such as deficiencies of complex IV (cytochrome c oxidase: 
COX) in mitochondrial respiratory chains, and the resultant onset of various clinical 
phenotypes. On the other hand, E18.5 embryos showed clinical phenotypes, even when they 
carried less than 70%–80% ∆mtDNA. These results suggest the possibility that threshold for 
tolerance to accumulation of ∆mtDNA in embryonic liver and blood cells would be lower 
than that in other tissues. Because electron microscopic observations of COX activity 
(COX-EM) can visualize COX activity in individual mitochondria of single cells (Nakada et 
al. 2001; Seligman et al. 1968), I next performed COX-EM with liver samples from E18.5 
embryos carrying various loads of ∆mtDNA. In liver samples carrying ≥50% ∆mtDNA, I 
observed three types of mitochondria in a single cytoplasm of hepatocytes, mitochondrion 
that appeared normal in COX activity (arrows in Figure 8A), a swollen mitochondrion with 
COX activity (closed arrowhead in Figure 8A), and a COX-deficient swollen mitochondrion 
(open arrowhead in Figure 8A). In blood cells of liver samples carrying ≥50% ∆mtDNA, 
heterogeneity of COX activity within individual mitochondria was clearly visible (Figure 8B), 
although swollen mitochondria were not observed. These observations indicated that ≥50% 
∆mtDNA loads could induce mitochondrial respiration defects in hepatocytes and blood cells 
of late-stage embryos. In addition, there were no autophagic double-membrane structures 
around abnormal mitochondria in hepatocytes or blood cells (Figure 8, A and B), indicating 
that that the COX-deficient mitochondria were not eliminated by the mitochondrial autophagy 
(mitophagy), even when a single cytoplasm contained mitochondria with different 
mitochondrial respiratory functions.  
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Changes of ∆mtDNA load and clinical phenotypes in mito-mice∆ during early life. 
 The results of the early life span described above (see Figure 2D) clearly showed 
that there were two populations of neonates carrying ≥50% ∆mtDNA in their tail; the first 
population showed death phenotypes in the first month after birth, probably due to PS-like 
phenotypes; and the second population were able to escape early death. In mito-mice∆, 
genetic variation is restricted to the load of ∆mtDNA in various tissues, so that phenotypes are 
strictly induced by the load of ∆mtDNA in affected tissues. Considering this point, there was 
a possibility that the ∆mtDNA load decreased preferentially in the peripheral blood and liver 
of surviving neonates by around 1-month after birth. To test this possibility, I examined 
∆mtDNA load in affected and non-affected tissues of surviving neonates at various time 
points up to and including day 34 after birth (Figure 9). In this assay, I could not trace the 
proportion of ∆mtDNA load in tissues from single neonates, because I had to sacrifice 
neonates to obtain tissue samples. Thus, I estimated the proportion of ∆mtDNA in each 
sample relative to that in the tail sample taken on day 0 after birth from the same subject. The 
animals were analyzed as two subgroups defined by the ∆mtDNA load in the tail (i.e,, <50% 
and ≥50% ∆mtDNA). In kidney samples as a non-affected tissue, the relative ratios increased 
with time in both subgroups, suggesting that the proportion of ∆mtDNA in the non-affected 
tissues increased independently of the ∆mtDNA load (Figure 9, P < 0.05). In peripheral blood, 
there were two distinct patterns dependent on ∆mtDNA load. In neonates carrying <50% 
∆mtDNA in their tails at day 0, the relative ratios increased with time (P < 0.05) and the 
pattern was similar to that of kidney samples. In neonates carrying ≥50% ∆mtDNA in their 
tails at day 0, the relative ratios in peripheral blood samples did not increase with time. The 
relative ratios in liver samples from both subgroups did not increase with time. In the case of 
liver samples from E18.5 embryos carrying ≥50% ∆mtDNA, however, a significant decrease 
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of relative ratios was observed (P < 0.05).  
To confirm changes in ∆mtDNA load in peripheral blood within same individuals, I 
collected peripheral blood samples from single neonates carrying 7%–64% ∆mtDNA, 
respectively, in their tails at day 0. I calculated the proportion of ∆mtDNA in peripheral blood 
on day 34 after birth relative to that on day 14 after birth (Figure 10). The relative ratios in 
surviving neonates carrying <50% ∆mtDNA in their tails were >1 and particularly high in 
neonates carrying <20% ∆mtDNA in their tails. In contrast, neonates carrying ≥50% 
∆mtDNA in their tails showed relative ratios <1. There was a significant difference between 
neonates carrying <50% and ≥50% ∆mtDNA in their tails (P < 0.05). These data indicate that 
the proportion of ∆mtDNA in peripheral blood decreased at an early age (i.e., from days 14 to 
34) when the proportion of ∆mtDNA in peripheral blood was ≥50%.  
Consistent with these results, abnormalities observed in peripheral blood and liver 
samples of E18.5 embryos carrying ≥50% ∆mtDNA in their tails (Figure 6, 7 and 8A) were 
not detected on day 34 after birth (Figure 11–13). There was no significant difference in 
reticulocyte number between wild-type mice and mito-mice∆ (Figure 11, A and B). Iron 
deposits that were seen in livers from late stage embryos carrying ≥50% ∆mtDNA were not 
observed in the livers carrying 47% ∆mtDNA, which was the maximum proportion of 
∆mtDNA observed on day 34 after birth (Figure 12) due to the decreased ∆mtDNA loads in 
liver. In COX-EM, abnormalities were not observed in liver samples (Figure 13). These 
findings indicate that the decrease of ∆mtDNA loading proportion in peripheral blood and 
liver of neonates carrying ≥50% ∆mtDNA in their tails would be one reason for recovering 
from PS-like phenotypes and for the resultant survival. 
 
Disease phenotypes of surviving neonates when they reach middle life. 
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 At 6 months of age or later, all the surviving mito-mice∆ showed lactic acidosis, 
heart block, renal failure, male infertility, deafness, and abnormalities in long-term memory as 
reported previously, when the proportion of ∆mtDNA in affected tissues reached 
approximately 70%-80% (Inoue et al. 2000; Nakada et al. 2001; Nakada et al. 2004; Nakada 
et al. 2006; Ogasawara et al. 2010; Tanaka et al. 2008). In some of surviving mito-mice∆ 
carrying >80% ∆mtDNA, retinal abnormalities were observed (Figure 14). These results 
indicated that neonates that remitted from PS-like phenotypes in early life expressed KSS-like 
phenotypes in their middle life. 
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Taking the current results together with previous studies of my colleagues, I 
summarized the development of mitochondrial diseases in mito-mice∆ (Figure 15). Based on 
the difference in ∆mtDNA loads and the resultant mitochondrial disease phenotypes, 
mito-mice∆ population is classified into four subgroups. The first subgroup is mito-mice∆ 
carrying ≤10% ∆mtDNA at the birth. They showed normal phenotypes, because ∆mtDNA 
loads did not reach >70%-80% in various tissues through the life (Normal subgroup in Figure 
15). The second subgroup is mito-mice∆ carrying 11%–49% ∆mtDNA just after birth, and the 
mice appeared healthy until middle age (6 months) or later, but when the ∆mtDNA load 
reached >70%-80% in various tissues, they expressed KSS-like phenotypes (Late-onset 
subgroup in Figure 15). The main clinical features in this subgroup, such as low body weight, 
lactic acidosis, heart block, renal failure, deafness, male infertility, and abnormal long-term 
memory, has been reported previously (Inoue et al. 2000; Nakada et al. 2001; Nakada et al. 
2004; Nakada et al. 2006; Ogasawara et al. 2010; Tanaka et al. 2008). The third and fourth 
subgroups are mito-mice∆ carrying ≥50% ∆mtDNA just after birth. When the ∆mtDNA load 
in late-stage embryos reached ≥50%, abnormalities of hematopoiesis and iron metabolisms in 
liver were induced, thus leading to PS-like phenotypes (i.e., abnormalities in hematopoiesis 
and iron metabolism; Figure 6 and 7), although >70%-80% ∆mtDNA loads were necessary 
for the onset of KSS-like phenotypes in adult mito-mice∆. Half of those expressing PS-like 
phenotypes died in early life (≤34 days after birth). The third subgroup, therefore, was the 
case of onset of PS-like phenotypes and the resultant early death (Early-onset and death 
subgroup in Figure 15). The rest escaped from the early death, because PS-like phenotypes in 
them disappeared consistent with a decrease of ∆mtDNA load in affected tissues (see Figure 
11 and 12 for the cases of peripheral blood and liver samples, respectively). However, they 
 20 
expressed KSS-like phenotypes, when ∆mtDNA load reached >70%-80% in affected tissues 
(Figure 14). Thus, the fourth subgroup was the case of transient onsets of PS-like and 
KSS-like phenotypes in early and middle age, respectively, in a single mito-mice∆ (Early-and 
late-onsets subgroup in Figure 15).  
Heterogeneous distribution of mitochondria with and without COX activity in 
single cells would be important for elucidating the reason why the pathogenic threshold load 
of ∆mtDNA in embryonic blood and liver was lower than that in other tissues. My colleagues 
have previously reported that a uniform distribution of mitochondria either with or without 
COX activity occurs in somatic cells of adult mito-mice∆, irrespective of whether the tissues 
contain low or high loads of ∆mtDNA (Nakada et al. 2001). This indicates the occurrence of 
mitochondrial genetic complementation in which individual mitochondria exchange gene 
products derived from mtDNA through their fusion and fission. Because mitochondria 
carrying ∆mtDNA can be supplied by mitochondria carrying wild-type mDNA, tissues 
carrying ∆mtDNA did not show mitochondrial respiration defects until ∆mtDNA accumulated 
to a level of >70%-80%. In contrast, here I observed that blood cells and hepatocytes in 
late-stage embryos showing PS-like phenotypes contained mitochondria with heterogenous 
ultra-structures and COX activity levels (Figure 8, A and B). This finding suggested the 
existence of deficiencies of mitochondrial fusion or fission or both, and a lack of 
mitochondrial genetic complementation in these late-stage embryonic cells. Such deficiencies 
could be one reason that a load of ≥50% ∆mtDNA could cause pathogenicity in blood cells 
and hepatocytes of late-stage embryos, whereas a higher load is required in adult mice. 
Moreover, it has been reported that mitochondrial dynamics, a continuous mitochondrial 
fusion and fission, is necessary to maintain normal mitochondrial respiratory function in 
mammals (Chen et al. 2010; Ishihara et al. 2009). Therefore, it is possible that deficiencies of 
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mitochondrial dynamics and genetic complementation in embryonic blood cells and 
hepatocytes enhance the pathogenicity of ∆mtDNA in the case of a ≥50% ∆mtDNA load. 
Interestingly, the significant increase in numbers of reticulocytes in peripheral blood 
samples from late-stage embryos with ≥50% ∆mtDNA, compared with those in normal 
controls, was not observed for 34-day-old mito-mice∆ with ≥50% ∆mtDNA (Fig. 11, A and 
B). Considering that mammalian hematopoiesis is classified into primitive and definitive 
forms, the latter of which is found in fetal liver and bone marrow after birth (Palis et al. 1998), 
my results suggested that hematopoietic cells locating in bone marrow showed a lower 
sensitivity to the accumulation of ∆mtDNA than those in embryonic liver. Thus, the change of 
hematopoietic organs from liver to bone marrow during early life could enable mito-mice∆ 
carrying ≥50% ∆mtDNA to escape death from PS-like phenotypes. 
Because changes in the proportion of ∆mtDNA in affected tissues were highly 
associated with the development of different mitochondrial disease spectrums in mito-mice∆, 
I propose that the dynamics of the ∆mtDNA load in affected tissues is one reason for the 
transition from PS-like to KSS-like phenotypes in single individuals. In this study, I observed 
two types of regulation in the dynamics of ∆mtDNA load (i.e., positive and negative). 
Accumulation of ∆mtDNA in various somatic cells (positive regulation), such as kidney, was 
considered responsible for the onset of KSS-like phenotypes in mito-mice∆ during middle life. 
Decreased ∆mtDNA load (negative regulation), was classified into two different modes of 
action. One was a ∆mtDNA load-dependent negative regulation that was seen in peripheral 
blood samples of mito-mice∆ in early life. With the recovery from PS-like phenotypes 
proceeded, there was a tendency that proportion of ∆mtDNA decreased in peripheral blood 
samples. Taking this finding together with the change of hematopoietic organs from liver to 
bone marrow during early life, the ∆mtDNA load-dependent negative regulation might be 
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necessary to remit from PS-like phenotypes. The other mode of action is the ∆mtDNA 
load-independent negative regulation that was seen in the liver of mito-mice∆. In late-stage 
embryos and neonates of mito-mice∆, the proportions of ∆mtDNA of liver were always lower 
than those in other embryonic tissues. The biological and clinical significance of this 
phenomenon remains to be answered. 
Abnormal mitochondria are selectively degraded by autophagy, a process involved 
in protein and organelle turnover (Mizushima et al. 2008). Mitophagy is essential for 
biogenesis in yeast (Okamoto et al. 2009; Kanki et al. 2009), and experimental mitophagy in 
mammalian cultured cells is triggered by an acute disruption of the mitochondrial membrane 
potential (Narendra et al. 2008; Matsuda et al. 2010). The difference in individuality of each 
mitochondrion is considered to be a primary trigger for the occurrence of mitophagy in the 
vital state, so that it is possible that mitochondria with respiration defects are eliminated by 
mitophagy. Results of the COX-EM (Fig. 8, A and B), however, clearly showed that 
COX-positive and COX-negative mitochondria coexisted in single cytoplasms of blood cells 
and hepatocytes, and ultra-structural changes characteristic of mitophagy were not observed 
around COX-negative mitochondria. These findings suggested that the COX-negative 
mitochondria were not eliminated by the mitophagy, even when a single cytoplasm contained 
mitochondria with different mitochondrial respiratory functions. Consistent with this result, 
my colleagues previously observed a uniform distribution of COX-negative mitochondria 
without autophagic ultra-structures in cardiac muscle tissues and renal cells in the state of a 
high load of ∆mtDNA (Nakada et al. 2001). Therefore, chronic mitochondrial respiration 
defects induced by the accumulation of ∆mtDNA might be insufficient as a trigger for 
mitophagy, at least in the mammalian tissues examined here. 
PS-like phenotypes induced by the abnormalities of hematopoiesis and iron 
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metabolisms in livers of late-stage embryos carrying ≥50% ∆mtDNA were the main clinical 
features, but it is unclear why a half of the neonates carrying ≥50% ∆mtDNA died early. 
There are several possible explanations for this phenomenon. The first is that the pups might 
have suffered acute oxidative stress, because newborns and infants are particularly prone to 
oxidative stress (Saugstad. 2005). Newborns and infants have reduced antioxidant defense 
mechanisms as well as high levels of free iron, which are required for the Fenton reaction 
(Saugstad. 2005); approximately 20% neonates died on day 1 after birth even in wild-type B6 
mice (Figure 2, A and B). Since neonates carrying ≥50% ∆mtDNA in their tails possessed iron 
deposits in liver (Figure 7), the high level of iron could promote the Fenton reaction, resulting 
in additional oxidative stress when the neonates are exposed to a high oxygen concentration 
after delivery (Singer and Muhlfeld. 2007). Another possibility was that abnormalities in 
metabolic adaptation to the aerobic condition just after birth might cause frequent early death 
in mito-mice∆. Anaerobic glycolysis is the major source of cellular ATP in fetal tissues. In 
cells with mitochondrial respiration defects due to pathogenic mutant mtDNAs, glycolysis is 
enhanced as a compensatory mechanism to maintain ATP levels. Therefore, ∆mtDNA might 
not demonstrate its pathogenicity in various cells during embryogenesis. Supporting this 
notion, I observed only rare incidents of embryonic lethality in mito-mice∆. After birth, 
neonates carrying ∆mtDNA have to change from anaerobic to aerobic energy metabolism in 
various cells as soon as possible, but they would find this process difficult due to their 
systemic and chronic mitochondrial respiration defects.  
In summary, my model mouse study showed that a single ∆mtDNA molecule has a 
pathogenic potential to cause PS-like and KSS-like phenotypes at early and middle life, 
respectively, and also suggested that difference in threshold for tolerance to accumulation of 
∆mtDNA in affected tissues between young infants and adults is a possible reason for the 
 24 
onset of disease phenotypes in mito-mice∆. In addition, dynamics of ∆mtDNA load in 
affected tissues well correlated with the transition of disease phenotypes in mito-mice∆. 
Considering that preferential accumulation of pathogenic mutant mtDNAs has 
been reported in some cases of cancer, diabetes, neurodegenerative diseases, and 
aging, the dynamics of pathogenic mtDNAs in affected tissues would cause a wide 
variety of mutant mtDNA-based disorders. Therefore, I believe that my findings 
will be of great interest in the field of genetics and medical sciences. 
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Figure 1 
Gene map of ∆mtDNA introduced in mito-mice∆. 
 
A wild-type mtDNA (left) is a circular DNA (16.3 kbp ) and encodes 37 genes including 13 
mRNAs, 22 tRNAs, and 2 rRNAs. A mtDNA with a large-scale deletion (∆mtDNA; right) 
introduced in mito-mice∆ is 11.3 kbp in size, because 13 genes including 7 mRNAs and 6 
tRNAs (arc) are lost by a deletion. Single capitals in maps indicate tRNA genes. 
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Figure 2 
Observations of mito-mice∆ on the early life. 
 
(A) Frequency of neonatal death in mito-mice∆ carrying 1%–70% ∆mtDNA in their tails. 
Neonates of mito-mice∆ were classified into four groups carrying 1%–34% (n = 23), 
35%–49% (n = 30), 50%–59% (n = 42), and 60%–70% (n = 31) ∆mtDNA, respectively, in 
their tails. Neonates of wild-type B6 mice were used as normal controls (n = 30). (B)–(D) 
Life span of mito-mice∆ carrying 1%–70% ∆mtDNA in their tails was assessed for days 1 to 
34. Based on the observed frequency of neonatal death in mito-mice∆ (see panel A), neonates 
of mito-mice∆ were classified into two groups carrying 1%–49% (n = 53) (C) and 50%–70% 
(n = 73) (D) ∆mtDNA in their tails, and the life span of each group was examined. The life 
span of wild-type B6 mice was also examined as a normal control (n = 30) (B). Survival 
curves were compared between mito-mice∆ carrying 1%–49% ∆mtDNA and wild-type B6 
mice (P = 0.3054, log-rank test) and between mito-mice∆ carrying 50%–70% ∆mtDNA and 
wild-type B6 mice (P < 0.0001, log-rank test).  
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Figure 3 
Relationship between early death and ∆mtDNA load in mito-mice∆. 
 
Comparison of ∆mtDNA proportion in tail samples from pups and mothers. Open circles and 
red crosses indicate pups that were alive and dead, respectively, at 34 days after birth. 
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Figure 4 
The rate of early death in the first and second litters. 
 
(A) Comparison between first and second litters in terms of pup survival and ∆mtDNA 
proportion in the tails of pups. Three female mito-mice∆ carrying 28% (Mouse 28), 52% 
(Mouse 52), and 61% (Mouse 61) ∆mtDNA in their tails just after birth (day 0) were used in 
this assay. Open circles and red crosses indicate the proportions of ∆mtDNA in the tails of 
pups that were alive and dead, respectively, at 34 days after birth. Blue symbols indicate the 
proportions of ∆mtDNA in mothers’ tails. (B) Comparison between the first and second 
deliveries in terms of survival rates of pups from Mouse 28, Mouse 52, and Mouse 61 at day 
34 after birth. Data are presented as mean ± SD. Asterisk indicates significant differences (P 
< 0.05). 
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Figure 5 
Characteristics of late-stage embryos of mito-mice∆. 
 
All embryos were obtained at embryonic day 18.5. (A) Morphological observation of late 
stage embryos carrying 0%–66% ∆mtDNA in their tails, as indicated. The embryo carrying 
no ∆mtDNA (left side) was a wild-type B6 control. The six embryos carrying ∆mtDNA were 
obtained from a single mother. The weight of each embryo is shown below the panel. (B) 
Comparison of littermate number. Average numbers of littermates from 2-month-old female 
mito-mice∆ carrying 0% (white), 1%–32% (gray), or 33%–63% (black) ∆mtDNA. Data are 
presented as mean ± SD. NS, not significant. (C) Relationship between weight and ∆mtDNA 
load in late-stage embryos carrying 0% (white), 34%–47% (gray), or 52%–66% (black) 
∆mtDNA. Data are presented as mean ± SD. Asterisks indicate significant differences (P < 
0.05). 
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Figure 6 
Hematological observations of late-stage embryos of mito-mice∆. 
 
(A) Hematological observation of peripheral blood samples from late-stage embryos. 
Peripheral blood samples carrying 0%, 36%, and 59% ∆mtDNA, respectively, were stained 
with new methylene blue. In this method, reticulocytes, a type of immature red blood cell 
(RBC), are visualized as cells with blue inclusions (open arrowheads). Scale bar, 10 μm. (B) 
Average proportion of reticulocytes in total RBCs in peripheral blood samples from late-stage 
embryos carrying 0% (white), 34%–42% (gray), or 52%–65% (black) ∆mtDNA. Data are 
presented as mean ± SD. Asterisks indicate significant differences (P < 0.05). 
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Figure 7 
Histological observations of late-stage embryos of mito-mice∆. 
 
Histological observations of iron metabolism in liver samples from late-stage embryos. Liver 
samples carrying 0%, 41%, and 55% ∆mtDNA, respectively, were stained with Prussian blue. 
In this method, abnormal iron metabolism is visualized as blue deposits. Scale bar, 10 μm.  
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Figure 8 
Electron microscopic observations of late-stage embryos of mito-mice∆. 
 
(A) and (B) Electron microscopic observations of COX activity in liver samples from 
late-stage embryos. Mitochondria in hepatocytes and blood cells are shown as (A) and (B), 
respectively. Arrows indicate mitochondria that appeared normal in shape and COX activity, 
open arrowheads indicate COX-deficient mitochondria, and the closed arrowheads indicate 
swollen mitochondria with COX activity. N, nucleus. Scale bar, 1 μm. 
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Figure 9 
Dynamics of the proportion of ∆mtDNA in early life of mito-mice∆. 
 
Dynamics of the proportion of ∆mtDNA in affected (peripheral blood and liver) and 
non-affected (kidney) tissues at various time points up to and including day 34 after birth. 
White and black bars indicate populations of mito-mice∆ carrying <50% and ≥50% ∆mtDNA 
in tail samples, respectively. The relative ratio is the proportion of ∆mtDNA in the tissue 
tested relative to that in the tail of the same individual at day 0 after birth. Data are presented 
as mean ± SD. Asterisks indicate significant differences (P < 0.05). NS, not significant. 
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Figure 10 
Dynamics of the proportion of ∆mtDNA in blood within the same individuals. 
 
Dynamics of the proportion of ∆mtDNA in peripheral blood samples from single individuals 
during early life. Red and blue symbols indicate cases where the proportion of ∆mtDNA in 
peripheral blood samples increased and decreased, respectively, between days 14 and 34 after 
birth. Asterisk indicates significant differences (P < 0.05).  
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Figure 11 
Hematological observations of mito-mice∆ at day 34 after birth. 
  
(A) Hematological observations of peripheral blood samples obtained from mito-mice∆ at day 
34 after birth. Peripheral blood samples carrying 0%, 38%, and 59% ∆mtDNA, respectively, 
were stained with new methylene blue and reticulocytes (open arrowheads) are visualized 
similar to Figure 6A. Scale bar, 10 μm. (B) Average proportions of reticulocytes in total RBC. 
Results for peripheral blood samples obtained from mito-mice∆ carrying 0%, 7%–38%, and 
53%–64% ∆mtDNA are shown as white, gray, and black colors, respectively. Data are 
presented as mean ± SD. NS, not significant. 
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Figure 12 
Histological observations of mito-mice∆ at day 34 after birth. 
 
Histological observations of iron metabolism in liver samples from mito-mice∆ at day 34 
after birth. Liver samples carrying 0%, 38%, and 47% ∆mtDNA, respectively, were stained 
with Prussian blue. Scale bar, 10 μm. 
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Figure 13 
Electron microscopic observations of mito-mice∆ at day 34 after birth. 
 
COX-EM of liver samples obtained from mito-mice∆ at day 34 after birth. The COX-EM of 
liver samples carrying 0%, 25%, and 47% ∆mtDNA, respectively, are shown. The loading of 
47% ∆mtDNA was the maximum in the liver samples that I examined at day 34, because the 
proportion of ∆mtDNA in liver was lower than that in tissues during early life. N, nucleus. 
Bar, 2 µm. 
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Figure 14 
Phenotypic observations of middle-aged mito-mice∆. 
 
Histological observations of retina from mito-mice∆ assayed at 6 months of age. Sections of 
eye samples were stained with hematoxylin and eosin. The proportion of ∆mtDNA in eye 
samples from the opposite side is indicated under the each picture. Scale bar, 50 µm. 
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Figure 15 
Schematic representation of disease phenotypes in mito-mice∆ population. 
 
“Normal” and “Late-onset” subgroups in mito-mice∆ populationn and their clinical features 
have already been reported as previous studies of my colleagues (Inoue et al. 2000; Nakada et 
al. 2001; Nakada et al. 2004; Nakada et al. 2006; Ogasawara et al. 2010; Tanaka et al. 2008). 
The novelty of this study was to found out two subgroups, “Early-onset and death” and 
“Early- and late-onsets” in addition of conventional two subgroups, “Normal” and 
“Late-onset” subgroups. 
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